Tempest Therapeutics Inc (TPST) Stock Price, Quote, News & History

TPSTNASDAQ
$0.8050
0.03124.03%
Last update: Sep 22, 10:12 AM

Tempest Therapeutics (TPST) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-20.73M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
7.23M
Free Cash Flow (TTM)
-20.73M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-13.50M

Analyst Rating and Forecast

12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$19.78M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-468.07%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.07

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
$0
Total Cash
$779.00K
Debt to Equity
-
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
$0

Key Statistics

Open
$0.78
Close
-
Volume / Avg.
198.92K / 2.46M
Day Range
$0.77 - $0.83
52 Wk Range
0.74 - 12.23
Market Cap
$13.31M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
4.75%
Days to Cover
2.03

About

Sector
Health Care
Industry
Biotechnology
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic pr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Tempest Therapeutics (TPST) stock?

A

You can purchase shares of Tempest Therapeutics (NASDAQ:TPST) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Tempest Therapeutics (TPST) competitors?

Q

What is the forecast, or price target, for Tempest Therapeutics (TPST) stock?

A

Tempest Therapeutics has a consensus price target of $28.33.

Q

What is the current price for Tempest Therapeutics (TPST)?

A

The stock price for Tempest Therapeutics (NASDAQ: TPST) is $0.805 last updated September 22, 2026 at 10:12 AM EDT.

Q

Does Tempest Therapeutics (TPST) pay a dividend?

A

There are no upcoming dividends for Tempest Therapeutics.

Q

When is Tempest Therapeutics (NASDAQ:TPST) reporting earnings?

A

Tempest Therapeutics does not have any upcoming earnings scheduled.

Q

Is Tempest Therapeutics (TPST) going to split?

A

There is no upcoming split for Tempest Therapeutics.

Q

What sector and industry does Tempest Therapeutics (TPST) operate in?

A

Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.